ATAI Life Sciences

ATAI Life Sciences is a clinical-stage biopharmaceutical company aimed at transforming the treatment of mental health disorders. ATAI Life Sciences was founded in 2018 to address the significant unmet needs and lack of innovation in the field of mental health treatments, as well as the emergence of previously overlooked or underutilized therapies, including psychedelic compounds and digital therapeutics. We have established a pipeline of 10 development programs and 6 enabling technologies, each led by a dedicated team with deep expertise in their respective fields and supported by our internal development and operational infrastructure.